Page 17 - Read Online
P. 17

Castán et al.                                                                                                                                           Radiology of hepatocarcinoma in non-cirrhotic patients

                           A                                 B
















                           C                                 D
















           Figure 6: Computed tomography obtained in axial planes (A) and arterial phase (B), portal phase (C), and late phase (D). Voluminous
           mass, encapsulated, with extensive necrosis and presence of multiple satellite lesions is identified in non-cirrhotic liver. The mass shows
           peripheral enhancement, predominantly in the arterial phase (B) and no contrast washout are observed in later phases (C, D). The findings
           are compatible with hepatocellular carcinoma with atypical behaviour
           assessment of hepatic parenchyma is a controversial   a lower prevalence of male presentation regarding
           choice. Di Martino et al. [44]  demonstrated that non-  HCC in cirrhotic liver. The average patient age at
                                                                                      [3]
           invasive diagnostic criteria of HCC are present in 90%   diagnosis is 65 years old.  There is little literature
           of cases and that the HCC in non-cirrhotic patients   on the radiological characteristics of this tumor in
           shows a similar pattern of enhancement as HCC in   non-cirrhotic liver. Winston et al. [47]  described the
           cirrhotic patients. Based on these results it would be   characteristics of MRI in 25 patients with HCC in non-
           reasonable to apply non-invasive diagnostic criteria   cirrhotic liver, compared with 11 patients with HCC in
           for HCC in non-cirrhotic patients if they have high   cirrhotic liver. In the group of non-cirrhotic patients,
           levels of α-fetoprotein.                           HCC usually presents as large masses (with an
                                                              average size of 12.4 cm), predominantly solitary or
           DIFFERENCES OF PRESENTATION OF HCC                 dominant with small satellite lesions (82% of patients)
           IN CIRRHOTIC VS. NON-CIRRHOTIC LIVERS              [Figure 6]. In patients with cirrhosis, tumors are
                                                              generally smaller. Their larger size and extent at time
           Ninety percent of HCC arise mainly in a liver with   of diagnosis in non-cirrhotic livers could be explained
           established cirrhosis resulting from chronic HCV or   by the non-inclusion of these patients in prevention
           HBV infection or alcohol related liver disease. [45]  programs. In healthy livers, there is a predisposition
                                                              for HCC to occur in the right hepatic lobe. [48]
           Radiologists are used to see the imaging of HCC that
           arises in cirrhotic livers. In these cases, the tumor   The usually well-differentiated HCC is an encapsulated
           is often multifocal or diffuse and small in relation   tumor  with  circumscribed  margins,  while  poorly
           to the screening area visualized in these patients.   differentiated HCC is an aggressive tumor that is not
           HCC in non-cirrhotic liver is an uncommon finding   encapsulated and has an ill-defined outline [Figure 7].
           for radiologists, presenting with different clinical and   These findings are more prevalent in HCC in cirrhotic liver
           treatment options as well as prognosis. [4,46]     whereas the HCC in non-cirrhotic liver is predominantly
                                                              moderate or well differentiated. [49]  This lesion may
           The setting of HCC in non-cirrhotic liver is twice   contain calcifications, necrosis, haemorrhage, and
           more common in men than in women, but there is     microscopic and macroscopic fat [Figure 8]. Sometimes,
                           Hepatoma Research ¦ Volume 3 ¦ January 12, 2017                                 9
   12   13   14   15   16   17   18   19   20   21   22